News

Filter

Vedolizumab has potential to offer improvement over infliximab in UC

30-04-2013

Surveyed US and EU5 gastroenterologists agree that new moderate to severe ulcerative colitis (UC) therapies…

EuropeGastro-intestinalsinfliximabJanssenMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRemicadeTakeda Pharmaceuticalsvedolizumab

Global ulcerative colitis drug market set to see “reasonable” growth to 2015

19-01-2010

According to Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015, a news report…

Drug DiscoveryGastro-intestinalsinfliximabMarkets & MarketingPharmaceuticalRemicadeSalix Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top